Cargando…
Macrophage activation syndrome: early diagnosis is key
Macrophage activation syndrome (MAS) is a life-threatening condition, and it is a subset of hemophagocytic lymphohistiocytosis (HLH). The clinical features include a persistent high-grade fever, hepatosplenomegaly, lymphadenopathy, hemorrhagic manifestations, and a sepsis-like condition. From the cl...
Autores principales: | Lerkvaleekul, Butsabong, Vilaiyuk, Soamarat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124446/ https://www.ncbi.nlm.nih.gov/pubmed/30214327 http://dx.doi.org/10.2147/OARRR.S151013 |
Ejemplares similares
-
The correlations of serum interleukin-6 (il-6) levels and serum soluble il-6 receptor levels with disease activity in systemic juvenile idiopathic arthritis patients with and without tocilizumab treatment
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2014) -
Factors associated with medication adherence among children with rheumatic diseases
por: Manatpreeprem, Roongroj, et al.
Publicado: (2023) -
Evaluating performance of the 2019 EULAR/ACR, 2012 SLICC, and 1997 ACR criteria for classifying adult-onset and childhood-onset systemic lupus erythematosus: A systematic review and meta-analysis
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2022) -
Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab
por: Vilaiyuk, Soamarat, et al.
Publicado: (2019) -
Recurrent ruptured abdominal aneurysms in polyarteritis nodosa successfully treated with infliximab
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2019)